Recently acquired by AstraZeneca, Arrow Therapeutics is a fully integrated private antiviral drug discovery, antiviral research and antiviral development company focused on antiviral therapies and drug discovery in areas of significant unmet medical need.

Within our focus on antiviral therapies and drug discovery, Arrow specialises in small molecule drugs with novel mechanisms of action and has a number of antiviral and drug discovery research and development programs, the most advanced of which target Respiratory Syncytial Virus (RSV) and Hepatitis C Virus (HCV).

LATEST NEWS

Ken Powell To Leave Arrow Therapeutics

19 January 2009

full story...

AstraZeneca Acquisition of Arrow Therapeutics Complete

2 March 2007

full story...

AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities

1 February 2007

full story...

PRODUCT PIPELINE